Xiao-Feng Lan
Biographic Data
| ID | 10423503 |
|---|---|
| NAME | Xiao-Feng Lan |
| GIVEN NAMES | Xiao-Feng |
| FAMILY NAME | Lan |
| SIGNATURE | LAN X |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Body mass index is associated with the antidepressant effects of intravenous ketamine in patients with depression
Our exploratory, post-hoc analysis of an open-label, single-arm study suggests that patients with depression and a higher baseline BMI may experience greater reductions in depressive symptoms compared with those with a lower baseline BMI after receiving six ketamine infusions
Plasma Vegf Concentrations and Ketamine's Effects on Suicidal Ideation in Depression With Suicidal Ideation
This preliminary finding does not support a role for VEGF in the antisuicidal effects of serial ketamine treatments in individuals with depression and suicidal ideation. Further research is needed to confirm and expand these findings
Association of Vegf With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
Objectives: To first explore the role of plasma vascular endothelial growth factor (VEGF) concentrations in ketamine's antianhedonic effects, focusing on Chinese patients with treatment-refractory depression (TRD). Methods: Seventy-eight patients with treatment-refractory major depressive disorder (MDD) or bipolar disorder (BD) were treated with six ketamine infusions (0.5 mg/kg). Levels of anhedonia were measured using the Montgomery-Åsberg Depr…
No prominent works on this page.
Association of Vegf With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
Objectives: To first explore the role of plasma vascular endothelial growth factor (VEGF) concentrations in ketamine's antianhedonic effects, focusing on Chinese patients with treatment-refractory depression (TRD). Methods: Seventy-eight patients with treatment-refractory major depressive disorder (MDD) or bipolar disorder (BD) were treated with six ketamine infusions (0.5 mg/kg). Levels of anhedonia were measured using the Montgomery-Åsberg Depr…
Plasma Vegf Concentrations and Ketamine's Effects on Suicidal Ideation in Depression With Suicidal Ideation
This preliminary finding does not support a role for VEGF in the antisuicidal effects of serial ketamine treatments in individuals with depression and suicidal ideation. Further research is needed to confirm and expand these findings
Body mass index is associated with the antidepressant effects of intravenous ketamine in patients with depression
Our exploratory, post-hoc analysis of an open-label, single-arm study suggests that patients with depression and a higher baseline BMI may experience greater reductions in depressive symptoms compared with those with a lower baseline BMI after receiving six ketamine infusions
Depression (economics (3 works) · Internal Medicine (3 works) · Ketamine (3 works) · Major depressive disorder (3 works) · Medicine (3 works) · Treatment of Major Depression (3 works) · Tryptophan and brain disorders (3 works) · Anesthesia (2 works) · Psychiatry (2 works) · Psychology (2 works)